Kanion Pharmaceutical(600557.SH)

Last Updated 00:00:00
longbridge loading
Company Encyclopedia
View More
name
Kanion Pharmaceutical
600557.SH
Jiangsu Kanion Pharmaceutical Co.,Ltd. researches and develops, produces, and sells Chinese medicines. It also offers medicines in the fields of anti-infections, orthopedics, gynecology, cardio and cerebrovascular, tonic-class, and others. In addition, the company provides herb extracts and formula granules, as well as OEM/ODM services.
2.805 T
600557.SHMarket value -Rank by Market Cap -/-

Financial Score

20/05/2026 Update
C
PharmaceuticalsIndustry
Industry Ranking116/215
Industry medianC
Industry averageC
Score Analysis
Peer Comparison
  • Criteria
    Rating
  • Profit ScoreB
    • ROE6.31%C
    • Profit Margin9.23%B
    • Gross Margin74.97%A
  • Growth ScoreD
    • Revenue YoY-4.99%D
    • Net Profit YoY-11.81%D
    • Total Assets YoY0.03%D
    • Net Assets YoY6.30%B
  • Cash ScoreC
    • Cash Flow Margin199.99%B
    • OCF YoY-4.99%D
  • Operating ScoreC
    • Turnover0.47C
  • Debt ScoreB
    • Gearing Ratio26.06%B

Valuation analysis

portai
P/E
1Y
3Y
5Y
10Y
P/E
-
Industry Ranking
-/-
  • P/E
  • Price
  • High
  • Median
  • Low
P/B
1Y
3Y
5Y
10Y
P/B
-
Industry Ranking
-/-
  • P/B
  • Price
  • High
  • Median
  • Low
P/S
1Y
3Y
5Y
10Y
P/S
-
Industry Ranking
-/-
  • P/S
  • Price
  • High
  • Median
  • Low
Dividend Yield
1Y
3Y
5Y
10Y
Dividend Yield
-
Industry Ranking
-/-
  • Dividend Yield
  • Price
  • High
  • Median
  • Low

Institutional View & Shareholder

Analyst Ratings

Rating
Percentage
    • Price
      --
    • Highest
      --
    • Lowest
      --
    News
    View More

    "Large Firms" China Merchants Securities initiates coverage on Kanion Pharmaceutical, expects the impact of centralized procurement to be digested

    AASTOCKS·
    SH
    512290
    -0.11%
    SH
    516500
    -0.68%
    SZ
    159316
    -0.98%
    AASTOCKS·
    SH
    512290
    -0.11%
    SH
    516500
    -0.68%
    SZ
    159316
    -0.98%

    Kanion Pharmaceutical: Wholly-owned subsidiary's drug receives approval for additional indications

    Zhitong·
    SH
    600557
    -2.04%
    Zhitong·
    SH
    600557
    -2.04%

    A-share weight loss drug concept stocks continued to weaken in the afternoon, Menovo hit the limit down, Medicilon and Kanion Pharmaceutical fell over 7%, SDKX and HISOAR had the largest declines

    Wallstreetcn·
    SH
    603538
    +4.41%
    SH
    600557
    -2.04%
    SH
    688136
    -4.30%
    Wallstreetcn·
    SH
    603538
    +4.41%
    SH
    600557
    -2.04%
    SH
    688136
    -4.30%

    The three major A-share indices rose collectively, with a significant increase in the biopharmaceutical sector. CPO continues to squeeze shorts, while Hong Kong stocks fluctuated and fell, tech stocks retreated, and government bonds and commodities declined

    Wallstreetcn·
    SZ
    002873
    -1.43%
    SH
    600557
    -2.04%
    SH
    603087
    +0.79%
    Wallstreetcn·
    SZ
    002873
    -1.43%
    SH
    600557
    -2.04%
    SH
    603087
    +0.79%

    Kanion Pharmaceutical: Clinical trial for Jianpi Shugan Guben Granules approved

    Zhitong·
    SH
    600557
    -2.04%
    Zhitong·
    SH
    600557
    -2.04%
    © 2026 Longbridge｜Disclaimer